PTC to commercialize two Akcea drugs in Latin America [Seeking Alpha]
AKCEA THERAPEUTICS (AKCA)
Last akcea therapeutics earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.akceatx.com/media-investors/press-releases
Company Research
Source: Seeking Alpha
Akcea Therapeutics ( AKCA ) inks an agreement with PTC Therapeutics ( PTCT ) under which the latter will commercialize TEGSEDI (inotersen) and WAYLIVRA (volanesorsen) in Latin America. Under the terms of the deal, PTC has exclusive rights to the two products in Latin America and certain Caribbean countries. Akcea will receive $12M upfront, $6M upon FDA or EMA approval of WAYLIVRA and mid-twenties royalties on net sales. Ionis Pharmaceuticals ( IONS ) receive 60% of all monies paid to Akcea from TEGSEDI and 50% of the monies from WAYLIVRA. TEGSEDI is indicated for stage 1 or 2 polyneuropathy in adult patients with hereditary transthyretin amyloidosis. WAYLIVRA is indicated for familial chylomicronemia syndrome. Click to subscribe to real-time analytics on AKCA Now read: Akcea Therapeutics: What The EU Tegsedi Approval Foretells » Subscribe for full text news in your inbox
Show less
Read more
Impact Snapshot
Event Time:
AKCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKCA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKCA alerts
High impacting AKCEA THERAPEUTICS news events
Weekly update
A roundup of the hottest topics